Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Adnavance Technologies makes appointment:

This article was originally published in Clinica

Executive Summary

Anthony Bihl, who retired in November 2007 as director of Siemens Medical Solutions' diagnostics division, has joined Adnavance Technologies (Vancouver, British Columbia) as an independent director. His more than 25-year career also features terms with Bayer Healthcare's diagnostics division (as president), Sterling Diagnostic Imaging and Dupont. Adnavance will use Mr Bihl's international experience to help approve and commercialise its proprietary diagnostic technology - the metalised-DNA (M-DNA) platform. M-DNA aims to obviate the need for the capital-intensive target amplification technology commonly used in molecular diagnostics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046373

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel